Advertisement
Screener

Edwards Lifesciences Corporation (EW) Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net

Edwards Lifesciences Corporation Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net

Edwards Lifesciences Corporation (EW) reported Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet · last filed 2018-10-26

  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2018-09-30 was $0.00.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-12-31 was $0.00.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2017-09-30 was $0.00.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2016-12-31 was $0.00.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2017 was $31.00M.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2016 was $0.00.
  • Edwards Lifesciences Corporation other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2015 was $0.00.
Period endOther than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 3 monthOther than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 6 monthOther than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 9 monthOther than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 12 month
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$0.00
10-Q · filed 2018-10-26
2018-06-30$0.00
10-Q · filed 2018-07-27
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$0.00
derived: sum of 2 quarters · filed 2018-10-26
$31.00M
10-K · filed 2018-02-16
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$31.00M
10-Q · filed 2018-10-26
2017-06-30$31.00M
10-Q · filed 2018-07-27
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$0.00
derived: sum of 2 quarters · filed 2018-02-16
$0.00
10-K · filed 2018-02-16
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
$0.00
10-Q · filed 2017-10-27
2016-06-30$0.00
10-Q · filed 2017-07-28
2015-12-31$0.00
10-K · filed 2018-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00